Atlas Trials

Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma

Clinical trial NCT01415063 · UNKNOWN

Trial details

NCT number
NCT01415063
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular CarcinomaRFATACE
Start date
2011-02-01
Primary completion
2013-03-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.